Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ferone

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Journal of Endocrinological Investigation|May 20, 1998
Height, weight, height velocity of primary school population sample in Campania regionB Merola, E Rossi, S Longobardi, et al.
Endocrine-Related Cancer|June 24, 2024
Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET studyE Baudin, J Capdevila, D Hörsch, et al.
Journal of Endocrinological Investigation|April 29, 2024
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective studyM Albertelli, G Rossi, E Nazzari, et al.
Journal of Endocrinological Investigation|March 15, 2018
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS)V Rochira, G Mossetto, N Jia, et al.
European Journal of Endocrinology|November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patientsM Filopanti, A M Barbieri, G Mantovani, et al.
Journal of Endocrinological Investigation|October 10, 2007
Pegvisomant in acromegaly: why, when, howA Colao, G Arnaldi, P Beck-Peccoz, et al.
Journal of Endocrinological Investigation|November 15, 2011
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management studyA Faggiano, P Ferolla, F Grimaldi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2011
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter studyM Filopanti, L Olgiati, G Mantovani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2021
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric studyS Massironi, D Campana, S Pusceddu, et al.
Pituitary|April 30, 2019
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivityL M Fatti, B Cangiano, G Vitale, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Endocrinological Investigation|May 20, 1998
Height, weight, height velocity of primary school population sample in Campania regionB Merola, E Rossi, S Longobardi, et al.
Endocrine-Related Cancer|June 24, 2024
Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET studyE Baudin, J Capdevila, D Hörsch, et al.
Journal of Endocrinological Investigation|April 29, 2024
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective studyM Albertelli, G Rossi, E Nazzari, et al.
Journal of Endocrinological Investigation|March 15, 2018
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS)V Rochira, G Mossetto, N Jia, et al.
European Journal of Endocrinology|November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patientsM Filopanti, A M Barbieri, G Mantovani, et al.
Journal of Endocrinological Investigation|October 10, 2007
Pegvisomant in acromegaly: why, when, howA Colao, G Arnaldi, P Beck-Peccoz, et al.
Journal of Endocrinological Investigation|November 15, 2011
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management studyA Faggiano, P Ferolla, F Grimaldi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2011
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter studyM Filopanti, L Olgiati, G Mantovani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2021
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric studyS Massironi, D Campana, S Pusceddu, et al.
Pituitary|April 30, 2019
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivityL M Fatti, B Cangiano, G Vitale, et al.
Pageof 14